Stay updated on Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page.

Latest updates to the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page
- Check6 days agoChange DetectedAdded a link to the Genetic and Rare Diseases Information Center under Resources and updated the page revision to 3.5.0 (replacing 3.4.3).SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page revision tag was updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedShow glossary feature has been added to the page, and the page now displays the label 'Last Update Submitted that Met QC Criteria' along with revision 'v3.4.0'. The previous label 'Last Update Submitted that met QC Criteria', the 'No FEAR Act data' entry, and the prior revision 'v3.3.4' were updated to reflect capitalization and version updates.SummaryDifference0.2%

- Check71 days agoChange DetectedThe page's revision indicator was updated from v3.3.3 to v3.3.4. This appears to be a metadata update with no visible changes to study content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page.